| Literature DB >> 27462071 |
Anders Bergström1, Sanne S Kaalund2, Kerstin Skovgaard3, Anders D Andersen1, Bente Pakkenberg4, Ann Rosenørn1, Ruurd M van Elburg5, Thomas Thymann1, Gorm O Greisen6, Per T Sangild7.
Abstract
Preterm pigs show many signs of immaturity that are characteristic of preterm infants. In preterm infants, the cerebellum grows particularly rapid and hypoplasia and cellular lesions are associated with motor dysfunction and cognitive deficits. We hypothesized that functional brain delays observed in preterm pigs would be paralleled by both structural and molecular differences in the cerebellum relative to term born piglets. Cerebella were collected from term (n = 56) and preterm (90% gestation, n = 112) pigs at 0, 5, and 26 days after birth for stereological volume estimations, large-scale qPCR gene expression analyses (selected neurodevelopmental genes) and western blot protein expression analysis (Sonic Hedgehog pathway). Memory and learning was tested using a T-maze, documenting that preterm pigs showed delayed learning. Preterm pigs also showed reduced volume of both white and gray matter at all three ages but the proportion of white matter increased postnatally, relative to term pigs. Early initiation of enteral nutrition had limited structural or molecular effects. The Sonic Hedgehog pathway was unaffected by preterm birth. Few differences in expression of the selected genes were found, except consistently higher mRNA levels of Midkine, p75, and Neurotrophic factor 3 in the preterm cerebellum postnatally, probably reflecting an adaptive response to preterm birth. Pig cerebellar development appears more affected by postconceptional age than by environmental factors at birth or postnatally. Compensatory mechanisms following preterm birth may include faster white matter growth and increased expression of selected genes for neurotrophic factors and regulation of angiogenesis. While the pig cerebellum is immature in 90% gestation preterm pigs, it appears relatively mature and resilient toward environmental factors.Entities:
Keywords: Enteral and parenteral nutrition; neonatal brain development; postconceptional age; prematurity
Mesh:
Substances:
Year: 2016 PMID: 27462071 PMCID: PMC4962075 DOI: 10.14814/phy2.12871
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Time lines for Experiments 1 and 2. The numbers on the preterm and term lines indicate postnatal days, whereas the numbers on the postconceptional age (PCA) line indicate postconceptional age, starting at day 106. The 12‐day difference in birth age between the groups is shown as “−12” on the line for term pigs. The T‐maze test was performed only for pigs in Experiment 1. Tissue sampling was done only for pigs from Experiment 2.
Fluidigm qPCR primer list
| Gene Symbol/primer | Gene description | Relevance | Sequence 5′ to 3′ |
|---|---|---|---|
| Adora2a (P1), F | Adenosine A2a receptor | Qiagen array suggestion | AGCTCCATCTTCAGCCTCCT |
| Adora2a (P1), R | CCAGTCACCAAGCCATTGTA | ||
| Adora2a (P2), F | Adenosine A2a receptor | Qiagen array suggestion | TGCTGAGTGAAGGGAGTGTG |
| Adora2a (P2), R | TTGAGGCCAGGGGACTCT | ||
| Atoh1 (P1), F | Atonal homolog 1 | Sonic Hedgehog Pathway | GCCAGTGCAGGAGGAAAGTA |
| Atoh1 (P1), R | GTAATGAGAATGCGGGGAAA | ||
| Atoh1 (P2), F | Atonal homolog 1 | Sonic Hedgehog Pathway | CAACTGTGCAAGCTGAAAGG |
| Atoh1 (P2), R | GTACCCCGTTCACCTGTTTG | ||
| Aqp4 (P1), F | Aquaporin 4 | Water transport | CCACGGTTCATGGAAATCTT |
| Aqp4 (P1), R | TCAGTCCGTTTGGAATCACA | ||
| Aqp4 (P2), F | Aquaporin 4 | Water transport | TACACCGGTGCCAGTATGAA |
| Aqp4 (P2), R | TGGTCCAACCCAATATATCCA | ||
| Bdnf, F | Brain‐derived neurotrophic factor | Neurotrophin | TTGAACACGTGATCGAGGAG |
| Bdnf, R | TCCGCGTCCTTATTGTTTTC | ||
| Calb1 (P1), F | Calbindin | Purkinje neuron marker | GGGCAAAGAGATGATGGAAA |
| Calb1 (P1), R | ATCGGAATAGCAGCAGGAAA | ||
| Calb1 (P2), F | Calbindin | Purkinje neuron marker | GGAGTCAAAATGTGTGGGAAA |
| Calb1 (P2), R | TGTATCCATTGCCATCCTGA | ||
| Casp3 (P1), F | Caspase‐3 | Proapoptotic | CTGGCAAACCCAAACTTTTC |
| Casp3 (P1), R | GTCCCACTGTCCGTCTCAAT | ||
| Casp3 (P2), F | Caspase‐3 | Proapoptotic | AGCAGTTTTATTTGCGTGCTT |
| Casp3 (P2), R | CAACAGGTCCATTTGTTCCA | ||
| Cldn3, F | Claudin‐3 | Tight junction marker | TTATCACAGCGCAGATCACC |
| Cldn3, R | ACACTTTGCACTGCATCTGG | ||
| Cldn5 (P1), F | Claudin‐5 | Tight junction marker | CTGGACCACAACATCGTGAC |
| Cldn5 (P1), R | AGCACCGAGTCGTACACCTT | ||
| Cldn5 (P2), F | Claudin‐5 | Tight junction marker | CTGGTTCGCCAACATCGT |
| Cldn5 (P2), R | AAGCTTCTCCTGCTCTGCTG | ||
| Dcx (P1), F | Doublecortin | Neurogenesis marker | CCTCAGGGAGTGCGTTACAT |
| Dcx (P1), R | ATAGCTTTCCCCTTCCTCCA | ||
| Dcx (P2), F | Doublecortin | Neurogenesis marker | TTGGTGACGACGATGTGTTT |
| Dcx (P2), R | TGACTCGGCATTCATTTTCA | ||
| Efnb1 (P1), F | Ephrin‐B1 | Qiagen array suggestion | AAATCCGCTTCACCATCAAG |
| Efnb1 (P1), R | CAGGCTCCCATTGGATGTAG | ||
| Efnb1 (P2), F | Ephrin‐B1 | Qiagen array suggestion | TGACCATCTTTTCCCTCCTG |
| Efnb1 (P2), R | GGGCAGATGATGTCCAGTTT | ||
| Erbb2 (P1), F | V‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 2 | Qiagen array suggestion | CAGCACATCCACCAGGAGT |
| Erbb2 (P1), R | AAGGTGCCAGTGGAGACTTG | ||
| Erbb2 (P2), F | V‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 2 | Qiagen array suggestion | CCCCAACACGACTCTAGCC |
| Erbb2 (P2), R | GGCAACGTAGCCATCAGTTT | ||
| Flk1 (P1), F | VEGF‐Receptor 2 | Angiogenesis pathway | GCATCCGAAGAGCTGAAAAC |
| Flk1 (P1), R | ATGCCACAGACTCCTTGCTT | ||
| Flk1 (P2), F | VEGF‐Receptor 2 | Angiogenesis pathway | ATCCCAGATGACAGCCAGAC |
| Flk1 (P2), R | ATGGCGCTAATTTGGTTCTG | ||
| Flt1 (P1), F | VEGF‐Receptor 1 | Angiogenesis pathway | GAAAGGCCAAGATTTGTGGA |
| Flt1 (P1), R | AGTCTTTGCCGTCCTGTTGT | ||
| Flt1 (P2), F | VEGF‐Receptor 1 | Angiogenesis pathway | CTACAAGCAGCCCATCACAA |
| Flt1 (P2), R | CGATGAATGCACTTTCTGGA | ||
| GFAP (P1), F | Glialfibrillaryacidic protein | (Bergmann) gliacell marker | ACATCGAGATCGCCACCTAC |
| GFAP (P1), R | GCAGATTGGAGAAGGTCTGC | ||
| GFAP (P2), F | Glialfibrillaryacidic protein | (Bergmann) gliacell marker | GCAGACCTTCTCCAATCTGC |
| GFAP (P2), R | CTCCACAGTCTTCACCACGA | ||
| Glut1 (P1), F | Glucose transporter 1 | Energy metabolism | GTCACCATCCTGGAGCTGTT |
| Glut1 (P1), R | ATAGAAAACCGCGTTGATGC | ||
| Glut1 (P2), F | Glucose transporter 1 | Energy metabolism | GCATCAACGCGGTTTTCTAT |
| Glut1 (P2), R | GTGGCATACACAGGCTGCT | ||
| Glut3 (P1), F | Glucose transporter 3 | Energy metabolism | TCCCCTCAGCTGCATTCTAT |
| Glut3 (P1), R | CCAGAAGACAACGAGGAAGC | ||
| Glut3 (P2), F | Glucose transporter 3 | Energy metabolism | GCTGGCGTGGTTAATACCAT |
| Glut3 (P2), R | CTCCAAGGCCTATCAGATGC | ||
| Gpr124 (P1), F | Probable G‐protein‐coupled receptor 124 | Angiogenesis regulator | GCTGTGCTCATGGAACTGAG |
| Gpr124 (P1), R | GAGAAGAGGCAGAGCAGCAG | ||
| Gpr124 (P2), F | Probable G‐protein‐coupled receptor 124 | Angiogenesis regulator | TCTGCCTCTTCTCCACCATC |
| Gpr124 (P2), R | CATGTGGAAGCACAGGTTCA | ||
| Hdac4 (P1), F | Histone deacetylase 4 | Qiagen array suggestion | CATTGACATCCACAGCCAGT |
| Hdac4 (P1), R | TTCCTCGTTCTCGCACTTCT | ||
| Hdac4 (P2), F | Histone deacetylase 4 | Qiagen array suggestion | TCTCTGCTTTGCTGGGAAAC |
| Hdac4 (P2), R | CGGAGTTGTCGTAGGGTCTC | ||
| HIF‐1a (P1), F | Hypoxia‐inducible factor 1‐alpha | Hypoxia marker | GAATGGAACGGAGCAAAAGA |
| HIF‐1a (P1), R | TGATTGCCCCAGGAGTCTAC | ||
| HIF‐1a (P2), F | Hypoxia‐inducible factor 1‐alpha | Hypoxia marker | TGTGTTATCTGTCGCTTTGAGTC |
| HIF‐1a (P2), R | TTTCGCTTTCTCTGAGCATTC | ||
| ICAM1, F | Intercellularadhesionmolecule 1 | Tight junction marker | GGGGTCCATACAGGACACTG |
| ICAM1, R | CAGCTCGTACTTCTGCGACA | ||
| Itpr3 (P1), F | Inositol 1,4,5‐Trisphosphate Receptor, Type 3 | Purkinje neuron differentiation | GTCATGGACGTGGAGTTCCT |
| Itpr3 (P1), R | GAGGTCAAAGAGCAGGATGC | ||
| Itpr3 (P2), F | Inositol 1,4,5‐Trisphosphate Receptor, Type 3 | Purkinje neuron differentiation | TCTGCTCATGTGCATTGTCA |
| Itpr3 (P2), R | GGGAAGAGCGACTCATCTTTT | ||
| Lifeguard (P1), F | Lifeguard | Anti‐apoptotic | TACAACACCACATCCGTGCT |
| Lifeguard (P1), R | GTCGAACTTGGTCTGGAAGC | ||
| Lifeguard (P2), F | Lifeguard | Antiapoptotic | GGAGCAGGCGTGTTTACATT |
| Lifeguard (P2), R | TGAGGGCGCCAAAAATATAC | ||
| LOC100623510 (P1), F | Protein S100‐B‐like (no SusScrofaortholog) | Qiagen array suggestion | AGCTCATCAACAGCGAGCTT |
| LOC100623510 (P1), R | GCTGTCCAGTGTCTCCATGA | ||
| LOC100623510 (P2), F | Protein S100‐B‐like (no SusScrofaortholog) | Qiagen array suggestion | CAGGAGGTCGTGGACAAAGT |
| LOC100623510 (P2), R | GGTAACCATGGCGACAAAAG | ||
| Mbp (P1), F | Myelin Basic Protein | Myelinization marker | TGACTACAAACCGGCTCACA |
| Mbp (P1), R | TCCCAGCTTGAAGATTTTGG | ||
| Mbp (P2), F | Myelin Basic Protein | Myelinization marker | GGACTGTCCCTCAGCAGATT |
| Mbp (P2), R | GAGCCGGTTTGTAGTCAGGA | ||
| Mct1 (P1), F | Monocarboxylate transporter 1 | Energy (lactate) metabolism | CCGACTTCTGGCAAAAGAAC |
| Mct1 (P1), R | GGCTTCTCAGCAGCGTCTAT | ||
| Mct1 (P2), F | Monocarboxylate transporter 1 | Energy (lactate) metabolism | GGTGGAGGTCCTATCAGCAG |
| Mct1 (P2), R | GAAGGAAGCTGCAATCAAGC | ||
| Mct2 (P1), F | Monocarboxylate transporter 2 | Energy (lactate) metabolism | CTCACTTGGCCTCTGTGTGA |
| Mct2 (P1), R | AAAGATGCCTGGCAAGAAGA | ||
| Mct2 (P2), F | Monocarboxylate transporter 2 | Energy (lactate) metabolism | GGTCCCCACCCATTAGTTTT |
| Mct2 (P2), R | ATGGAGAGGGCTGAGGATTT | ||
| Mdk (P1), F | Midkine (neurite growth‐promoting factor 2) | Qiagen array suggestion | GAAGGCTCGGTACAATGCTC |
| Mdk (P1), R | TTTTCCCTTCCCTTTCTTGG | ||
| Mdk (P2), F | Midkine (neurite growth‐promoting factor 2) | Qiagen array suggestion | GGTGGCCAAAAAGAAAGACA |
| Mdk (P2), R | CACTCCGCAGTCCTTGCT | ||
| Neurog1 (P1), F | Neurogenin 1 | Qiagen array suggestion | GCCACTCTCTGACCCCAGTA |
| Neurog1 (P1), R | AGGCCTGGAAAGGAGAAAAG | ||
| Neurog1 (P2), F | Neurogenin 1 | Qiagen array suggestion | CTTCCCAGACGACAGCAAG |
| Neurog1 (P2), R | GCCAGAGCCCAGATGTAGTT | ||
| Ngf (P1), F | Nerve Growth Factor | Neurotrophin | TCAGCATTCCCTTGACACAG |
| Ngf (P1), R | AAGTTTGGGGTCCACAGTGA | ||
| Ngf (P2), F | Nerve Growth Factor | Neurotrophin | CAACAGGACTCACAGGAGCA |
| Ngf (P2), R | CTGTCGCACACCGAGAACT | ||
| Nrp1 (P1), F | Neuropilin 1 (VEGF ligand) | Qiagen array suggestion | TTCAAGAGGGGTCCTGAATG |
| Nrp1 (P1), R | GGCTGTTGGGGTATTTTTCA | ||
| Nrp1 (P2), F | Neuropilin 1 (VEGF ligand) | Qiagen array suggestion | TCGAAAGCTTTGACCTGGAG |
| Nrp1 (P2), R | CCAATATGGGGACCAACATC | ||
| Nrp2 (P1), F | Neuropilin 2 | Angiogenesis pathway | GTTACTGCCTTGCGTTCCTC |
| Nrp2 (P1), R | CATCCTCGTAGCCCTCTCTG | ||
| Nrp2 (P2), F | Neuropilin 2 | Angiogenesis pathway | CGACATGGAGTACCAGCAGA |
| Nrp2 (P2), R | GAGGAACGCAAGGCAGTAAC | ||
| Ntf3 (P1), F | Neurotrophin 3 | Neurotrophin | AGACTCGCTCAATTCCCTGA |
| Ntf3 (P1), R | CTGAAGGTCCACCATCTGCT | ||
| Ntf3 (P2), F | Neurotrophin 3 | Neurotrophin | CAAAACCTCCCAGACCTACG |
| Ntf3 (P2), R | ACAAGGCACACACACAGGAC | ||
| Ocln, F | Occludin | Tight junction marker | GACGAGCTGGAGGAAGACTG |
| Ocln, R | GTACTCCTGCAGGCCACTGT | ||
| p75 (P1), F | Nerve Growth Factor Receptor | Neurotrophin receptor | CGACAACCTCATCCCTGTCT |
| p75 (P1), R | GCTGTTCCACCTCTTGAAGG | ||
| p75 (P2), F | Nerve Growth Factor Receptor | Neurotrophin receptor | CTGCAAGCAGAACAAGCAAG |
| p75 (P2), R | TCTGGCTGTCCACAGAGATG | ||
| Pdgfr‐beta (P1), F | Platelet‐derived growth factor receptor beta | Tyrosinekinase receptors | CTCACCGTCATCTCCCTCAT |
| Pdgfr‐beta (P1), R | AGCTCACGGATTCGATCACT | ||
| Pdgfr‐beta (P2), F | Platelet‐derived growth factor receptor beta | Tyrosinekinase receptors | GAGCCATTCTCAGGCTACCA |
| Pdgfr‐beta (P2), R | GACATGAGGGCTTGCTTCTC | ||
| Pecam‐1 (P1), F | Platelet endothelial cell adhesion molecule | Endothelialcell marker | TTGGAAACCATGCAATGAAA |
| Pecam‐1 (P1), R | GGTCACTTCCACTTCCGTGT | ||
| Pecam‐1 (P2), F | Platelet endothelial cell adhesion molecule | Endothelialcell marker | ACACGGAAGTGGAAGTGACC |
| Pecam‐1 (P2), R | TCAGCTTTCCGGATTTCACT | ||
| Ptch, F | Patched receptor | Sonic Hedgehog Pathway | GCGTGGATGATGTTTTCCTT |
| Ptch, R | GCTTGAGGCATTCTCCAGTC | ||
| Pxn (P1), F | Paxilin | Angiogenesis pathway | CTCTCTCCCAGAGGGGAAAC |
| Pxn (P1), R | GTGGAGTGGTCTGGCTCTTC | ||
| Pxn (P2), F | Paxilin | Angiogenesis pathway | CTCCCCTGTGAACTTTCTGG |
| Pxn (P2), R | TTCCTGAGAAGGCAGGAGAA | ||
| Shh (P1), F | Sonic Hedgehog | Sonic hedgehog pathway | GCGACTTCCTCACCTTCTTG |
| Shh (P1), R | GGCTCTCTGGTCTCGATCAC | ||
| Shh (P2), F | Sonic Hedgehog | Sonic hedgehog pathway | AGCAGTTTATCCCCAACGTG |
| Shh (P2), R | TGTAATTGGGGGTGAGTTCC | ||
| Smo1, F | Smoothened receptor | Sonic Hedgehog Pathway | CAGCAAGATCAACGAGACCA |
| Smo1, R | GTGGCAGCTGAAAGTGATGA | ||
| Snf2 h (P1), F | SWI/SNF‐related matrix‐associated actin‐dependent regulator of chromatin subfamily A member 5 | Purkinje and granula cell development | TACAAGGTGCCTCGAAATCC |
| Snf2 h (P1), R | TCATCGTTAAGGGGTTCAGC | ||
| Snf2 h (P2), F | SWI/SNF‐related matrix‐associated actin‐dependent regulator of chromatin subfamily A member 5 | Purkinje and granula cell development | GAAAGGGGAGAGGCAAGAAT |
| Snf2 h (P2), R | TGTACCGTCCAATCTTCGTG | ||
| Syp (P1), F | Synaptophysin | Synaptogenesis marker | GGAATACCTGCAAGGAGCTG |
| Syp (P1), R | AGAGCACCAGGTTCAGGAAG | ||
| Syp (P2), F | Synaptophysin | Synaptogenesis marker | GTGACCTCTGGCCTCAACAC |
| Syp (P2), R | CTCCTTGAACACGAACCACA | ||
| TrkB (P1), F | BDNF/NT‐3 growth factors receptor | Neurotrophin receptor | TTGTGTGGCAGAAAATCTCG |
| TrkB (P1), R | GGTCTGAGGTTGGAGATTCG | ||
| TrkB (P2), F | BDNF/NT‐3 growth factors receptor | Neurotrophin receptor | GGGGCAATTTTGAATGAGTC |
| TrkB (P2), R | CGTGGTACTCCGTGTGATTG | ||
| VE‐Cad (P1), F | VascularEndothelialCadherin | Tight junction marker | AGAGCCTCATGGGGAAGAAT |
| VE‐Cad (P1), R | TCTGAGGAGAGGCTGAGGAG | ||
| VE‐Cad (P2), F | VascularEndothelialCadherin | Tight junction marker | AACACACCTCTGGGAAATGG |
| VE‐Cad (P2), R | TGTCAAAGGGTGTGCTGAAG | ||
| Vegf‐A, F | Vascular endothelial growth factor A | Angiogenesis pathway | ACATCTTCAAGCCGTCCTGT |
| Vegf‐A, R | ACACTCCAGACCTTCGTCGT | ||
| Vegf‐B (P1), F | Vascular endothelial growth factor B | Neurotrophin pathway | GTGAAGCCAGACAGGGTTTC |
| Vegf‐B (P1), R | GTGGGATGGGTGATGTCAG | ||
| Vegf‐B (P2), F | Vascular endothelial growth factor B | Neurotrophin pathway | CTCTGGCCACCAAAAGAAAG |
| Vegf‐B (P2), R | TCCATGGTTAGAGGCACCAC | ||
| Wnt7a (P1), F | Wingless type, member 7A | Embryogenesis and angiogenesis marker | GCCTGGACGAGTGTCAGTTT |
| Wnt7a (P1), R | GCTCCCCACTTTGAGCTCTT | ||
| Wnt7a (P2), F | Wingless type, member 7A | Embryogenesis and angiogenesis marker | ATCAAGAAGCCGCTGTCCTA |
| Wnt7a (P2), R | GGTCCTCCTCGCAGTAGTTG | ||
| Wnt7b (P1), F | Wingless type, member 7B | Embryogenesis and angiogenesis marker | CGCGAGATCAAGAAAAACG |
| Wnt7b (P1), R | CACTTGCACTCCAGCTTCAT | ||
| Wnt7b (P2), F | Wingless type, member 7B | Embryogenesis and angiogenesis marker | GCTACGGCATCGACTTCTCC |
| Wnt7b (P2), R | TCGTTGTTGTGCAGGTTCAT | ||
| ZO‐1 (P1), F | Tight junction protein 1 | Tight junction marker | ATGACTCCTGACGGTTGGTC |
| ZO‐1 (P1), R | TGCCAGGTTTTAGGATCACC | ||
| ZO‐1 (P2), F | Tight junction protein 1 | Tight junction marker | CCGCCTCCTGAGTTTGATAG |
| ZO‐1 (P2), R | CAGCTTTAGGCACTGTGCTG | ||
| Beta‐actin, F | Beta‐actin | Reference gene | CTACGTCGCCCTGGACTTC |
| Beta‐actin, R | GCAGCTCGTAGCTCTTCTCC | ||
| B2 m, F | Beta‐2‐microglobulin | Reference gene | TGAAGCACGTGACTCTCGAT |
| B2 m, R | CTCTGTGATGCCGGTTAGTG | ||
| Gapdh, F | Glyceraldehyde 3‐phosphate dehydrogenase | Reference gene | ACCCAGAAGACTGTGGATGG |
| Gapdh, R | AAGCAGGGATGATGTTCTGG | ||
| PP1a, F | Protein phosphatase 1 alpha | Reference gene | CAAGACTGAGTGGTTGGATGG |
| PP1a, R | TGTCCACAGTCAGCAATGGT | ||
| Rpl13A, F | 60S ribosomal protein L13a | Reference gene | ATTGTGGCCAAGCAGGTACT |
| Rpl13A, R | AATTGCCAGAAATGTTGATGC | ||
| Tbp, F | Tatabox‐binding protein | Reference gene | ACGTTCGGTTTAGGTTGCAG |
| Tbp, R | CAGGAACGCTCTGGAGTTCT |
List of genes, relevance and primer sequences used for Fluidigm qPCR. P1 and P2 states the two “names” given for all newly designed primer sets. Reference genes are given as the last six in the gene list.
Figure 2T‐maze experiment. T‐maze test using term (black symbols, n = 6) and preterm (white symbols, n = 17) pigs. Each symbol represents average performance (mean ± SEM) of all pigs and of all ten trials for each of six consecutive days (A1–A6), starting on postnatal day 15. The term pigs reached the learning criterion (80% correct choices) 3 days before the preterm pigs (*P < 0.05).
Figure 3Postnatal comparison of cerebellar volumes. For both white matter (A) and gray matter (B), the cerebellar volumes were smaller for preterm (gray bars), relative to term (white bars) pigs at all measured ages (*P < 0.05, **P < 0.01, ***P < 0.001). The gray/white matter ratio (C) was higher in preterm pigs at birth (*P < 0.05).
Figure 4Development of cerebellar gray and white matter volumes. Each symbol shows a volume estimate for a single pig (black circles = gray matter, open circles = white matter. Dotted lines display the linear fit of volume as a function of postconceptional age of PCA 106, 118, 123, and 144 corresponding to preterm postnatal age 0, and term postnatal ages 0, 5, and 26 days. The shaded gray area shows the prediction intervals for the linear fits. The black bars shows means ± confidence intervals for PCA 111 and 132, corresponding to preterm postnatal age 5, and 26 days. The observed means for PCA 111 and 132 were not significantly different from the expected values calculated from the growth curves (P > 0.05). The total relative growth from 90% gestation to 26 days in term pigs was 108 and 64% for white and gray matter, respectively.
qPCR results
| Gene category/annotation | Gene | Day 26/Day 0 (Preterm + Term) | Preterm/term (Day 0) | Preterm/term (Day 26) |
|---|---|---|---|---|
| Neurotrophic factors/receptors | Bdnf | 2.1 | ||
| Ntf3 (P1) | 1.5 | 1.5 | ||
| Ntf3 (P2) | 2.1 | 1.9 | 1.7 | |
| p75 (P1) | 0.7 | 1.5 | 1.4 | |
| p75 (P2) | 0.7 | 1.5 | 1.7 | |
| Neurogenesis/angiogenesis | Dcx (P1) | 0.4 | 1.4 | |
| Dcx (P2) | 0.4 | 1.5 | ||
| Efnb1 (P1) | 0.7 | 1.4 | ||
| Efnb1 (P2) | 0.6 | 1.4 | ||
| Mdk (P1) | 1.6 | 1.7 | ||
| Mdk (P2) | 1.4 | 1.6 | ||
| Nrp1 (P1) | 0.7 | |||
| Nrp1 (P2) | 0.7 | |||
| Hypoxia | Hif‐1a (P1) | 1.4 | ||
| Hif‐1a (P2) | 1.5 | |||
| Sonic hedgehog pathway | Atoh1 | 0.5 | ||
| Tight junction | Icam1 | 0.4 |
Ratios of mean values of Day26/Day0 and Preterm/Term for differentially expressed genes by Fluidigm qPCR. *P < 0.05, **P < 0.01, ***P < 0.001. Blank cell = not significant (P > 0.05) or 0.75/0.5 < mean expression value ratio <1.5/2 for 2 or 1 primer sets, respectively. Note that for p75, Efnb1, Dcx, and Mdk, a borderline mean value ratio of 1.4 was included.